A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.
This article proposes a new semiparametric Bayesian hierarchical model for the joint modeling of longitudinal and survival data. We relax the distributional assumptions for the longitudinal model using Dirichlet process priors on the parameters defining the longitudinal model. The resulting posterior distribution of the longitudinal parameters is free of parametric constraints, resulting in more robust estimates. This type of approach is becoming increasingly essential in many applications, such as HIV and cancer vaccine trials, where patients' responses are highly diverse and may not be easily modeled with known distributions. An example will be presented from a clinical trial of a cancer vaccine where the survival outcome is time to recurrence of a tumor. Immunologic measures believed to be predictive of tumor recurrence were taken repeatedly during follow-up. We will present an analysis of this data using our new semiparametric Bayesian hierarchical joint modeling methodology to determine the association of these longitudinal immunologic measures with time to tumor recurrence.
Brown
Elizabeth R
ER
Department of Biostatistics, University of Washington, Seattle, Washington 98195, USA. elizab@u.washington.edu
Ibrahim
Joseph G
JG
D001499:Bayes Theorem; D019496:Cancer Vaccines / Q000276:immunology / Q000592:standards; D002986:Clinical Trials as Topic / Q000379:methods; D005678:G(M2) Ganglioside / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000592:standards; D008137:Longitudinal Studies; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D008954:Models, Biological; D015233:Models, Statistical; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000517:prevention & control; D016019:Survival Analysis
D019496:Cancer Vaccines; D005678:G(M2) Ganglioside